يعرض 1 - 18 نتائج من 18 نتيجة بحث عن '"Orozco Burbano, Juan David"', وقت الاستعلام: 0.58s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Electronic Resource
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
  9. 9
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Electronic Resource
  13. 13

    المصدر: Revista de la Facultad de Ciencias de la Salud Universidad del Cauca; Vol. 22 No. 2 (2020): Colecistectomía laparoscópica; 26-33
    Revista de la Facultad de Ciencias de la Salud Universidad del Cauca; Vol. 22 Núm. 2 (2020): Colecistectomía laparoscópica; 26-33

    وصف الملف: application/pdf

  14. 14
    Academic Journal

    المصدر: Revista Facultad Ciencias de la Salud: Universidad del Cauca, ISSN 0124-308X, Vol. 22, Nº. 2 (Colecistectomía laparoscópica), 2020, pags. 26-33

    وصف الملف: application/pdf

    Relation: https://dialnet.unirioja.es/servlet/oaiart?codigo=7921644; (Revista) ISSN 2538-9971; (Revista) ISSN 0124-308X

  15. 15
    Electronic Resource

    Additional Titles: Insuficiencia cardiaca con fracción de eyección conservada: ¿Cómo podemos abordarla?

    المصدر: Revista de la Facultad de Ciencias de la Salud Universidad del Cauca; Vol. 22 No. 2 (2020): Colecistectomía laparoscópica; 26-33; Revista de la Facultad de Ciencias de la Salud Universidad del Cauca; Vol. 22 Núm. 2 (2020): Colecistectomía laparoscópica; 26-33; 2538-9971; 0124-308X

    URL: http://revistas.unicauca.edu.co/index.php/rfcs/article/view/1489
    http://revistas.unicauca.edu.co/index.php/rfcs/article/view/1489/1378
    http://revistas.unicauca.edu.co/index.php/rfcs/article/view/1489/1378
    *ref*/Redfield M. Heart Failure with Preserved Ejection Fraction. New England Journal of Medicine. 2016;375(19):1868-1877.
    *ref*/Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure. 2016;18(8):891-975.
    *ref*/Oktay A, Shah S. Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons. Current Cardiology Reviews. 2014;11(1):42-52.
    *ref*/Oktay A, Rich J, Shah S. The Emerging Epidemic of Heart Failure with Preserved Ejection Fraction. Current Heart Failure Reports. 2013;10(4):401-410.
    *ref*/Gómez E. Identificación de pacientes con falla cardiaca y función sistólica preservada: Un estudio epidemiológico regional (I-PREFER Study) – Colombia. Revista Colombiana de Cardiología. 2013;20(2):58-67.
    *ref*/Tibrewala A, Yancy C. Heart Failure with Preserved Ejection Fraction in Women. Heart Failure Clinics. 2019;15(1):9-18.
    *ref*/Tromp J, MacDonald M, Tay W, Teng T, Hung C, Narasimhan C et al. Heart Failure With Preserved Ejection Fraction in the Young. Circulation. 2018;138(24):2763-2773.
    *ref*/Gupta D, Shah A, Castagno D, Takeuchi M, Loehr L, Fox E et al. Heart Failure With Preserved Ejection Fraction in African Americans. JACC: Heart Failure. 2013;1(2):156-163.
    *ref*/Lai Y, Wang L, Gladwin M. Insights into the Pulmonary Vascular complications of heart failure with Preserved Ejection Fraction. The Journal of Physiology. 2018;.
    *ref*/Borlaug B. The pathophysiology of heart failure with preserved ejection fraction. Nature Reviews Cardiology. 2014;11(9):507-515.
    *ref*/Cikes M, Claggett B, Shah A, Desai A, Lewis E, Shah S et al. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure. 2018;6(8):689-697.
    *ref*/Vaduganathan M, Patel R, Michel A, Shah S, Senni M, Gheorghiade M et al. Mode of Death in Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 2017;69(5):556-569.
    *ref*/Zile M, Litwin S. Heart Failure with a Preserved Ejection Fraction. En: Zipes D, Libby P, Bonow R, Mann D, Tomaselli G. Editors. Braunwald heart disease a textbooks of cardiovascular medicine. Eleventh edition. Philadelphia: ELSEVIER; 2019. P. 1287-1344
    *ref*/Lam C, Voors A, de Boer R, Solomon S, van Veldhuisen D. Heart failure with preserved ejection fraction: from mechanisms to therapies. European Heart Journal. 2018;39(30):2780-2792.
    *ref*/Meijers W, van der Velde A, de Boer R. Biomarkers in heart failure with preserved ejection fraction. Netherlands Heart Journal. 2016;24(4):252-258.
    *ref*/Iwano H, Little W. Heart failure: What does ejection fraction have to do with it?. Journal of Cardiology. 2013;62(1):1-3.
    *ref*/Mentz R, Kelly J, von Lueder T, Voors A, Lam C, Cowie M et al. Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction. Journal of the American College of Cardiology. 2014;64(21):2281-2293.
    *ref*/Hegde S, Claggett B, Shah A, Lewis E, Anand I, Shah S et al. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist). Circulation. 2017;136(11):982-992.
    *ref*/Pandey A, Parashar A, Kumbhani D, Agarwal S, Garg J, Kitzman D et al. Exercise Training in Patients With Heart Failure and Preserved Ejection Fraction. Circulation: Heart Failure. 2015;8(1):33-40.
    *ref*/Shah S, Kitzman D, Borlaug B, van Heerebeek L, Zile M, Kass D et al. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction. Circulation. 2016;134(1):73-90.
    *ref*/Pandey A, Patel K, Vaduganathan M, Sarma S, Haykowsky M, Berry J et al. Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure. 2018;6(12):975-982.
    *ref*/Yancy C, Jessup M, Bozkurt B, Butler J, Casey D, Drazner M et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure. Circulation. 2013;128(16).
    *ref*/de Denus S, O’Meara E, Desai A, Claggett B, Lewis E, Leclair G et al. Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation. New England Journal of Medicine. 2017;376(17):1690-1692.
    *ref*/Zheng S, Chan F, Nabeebaccus A, Shah A, McDonagh T, Okonko D et al. Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Heart. 2017;104(5):407-415.
    *ref*/Martin N, Manoharan K, Thomas J, Davies C, Lumbers R. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Cochrane Database of Systematic Reviews. 2018;.
    *ref*/Bavishi C, Chatterjee S, Ather S, Patel D, Messerli F. Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis. Heart Failure Reviews. 2014;20(2):193-201.
    *ref*/Solomon Scott, Mc Murray John, E et al. Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction- PARAGON HF The NEJM 2019 ; September 1: Pag1-11.
    *ref*/Sueta Daisuki, Yamamoto Eiichiro, et al. H2FPEF Score as a Prognostic Value in HFpEF patients. American Journal of Hypertension, 2019: Pag 1-37

  16. 16
    Academic Journal

    Alternate Title: Ischemic stroke in a young patient, is it needed to look for a thrombophilia? (English)

    المصدر: Revista Médica de Risaralda; ene-jun2022, Vol. 28 Issue 1, p105-113, 9p

  17. 17
  18. 18
    Periodical